
Tagg M 2mg/500mg Tablet SR
Marketer
Events Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Tagg M 2mg/500mg Tablet SR
Diabetac Duo 2mg/500mg Extended-Release tablets are an antidiabetic medication combining two active components for adult type 2 diabetes management. This formulation aids in blood glucose regulation. Administer Diabetac Duo with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose levels and potential complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication is a component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and blood tests (complete blood count and liver function tests) may be recommended by your doctor.
Uses of Tagg M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Tagg M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tagg M 2mg/500mg Tablet SR whole; do not crush, chew, or break it. Administer this medication with a meal.
Common Side effects of Tagg M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Tagg M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tagg M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Tagg M 2mg/500mg Tablet SR works:
Tagg M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption and Tagg M 2mg/500mg Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Tagg M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Prolonged-release Tagg M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Tagg M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Tagg M 2mg/500mg SR tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.
LiverCAUTION
Individuals with hepatic impairment should use Tagg M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically prescribed for patients with mild to moderate liver disease; the medication is contraindicated in those with severe liver dysfunction.
What if you forget to take Tagg M 2mg/500mg Tablet SR :
Should you forget to take a Tagg M 2mg/500mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tagg M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
